Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lyra Therapeutics, Inc. - Common Stock
(NQ:
LYRA
)
0.4950
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lyra Therapeutics, Inc. - Common Stock
Lyra Therapeutics Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for LYR-210 for the Treatment of Chronic Rhinosinusitis
June 08, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets
June 02, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics to Present at the William Blair 41st Annual Growth Stock Conference
June 01, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics To Present At The Jefferies Virtual Healthcare Conference
May 24, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 11, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference
May 06, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update
April 27, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual
April 11, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
